Treatment of endocrine dysfunction using iron chelators

Details for Australian Patent Application No. 2007280639 (hide)

Owner Novartis AG

Inventors Cabantchik, Ioav; Nick, Hanspeter

Agent Davies Collison Cave

Pub. Number AU-A-2007280639

PCT Pub. Number WO2008/015021

Priority 06118491.7 04.08.06 EP

Filing date 3 August 2007

Wipo publication date 7 February 2008

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61P 5/10 (2006.01) Drugs for disorders of the endocrine system

A61P 5/14 (2006.01) Drugs for disorders of the endocrine system

A61P 5/18 (2006.01) Drugs for disorders of the endocrine system

A61P 5/48 (2006.01) Drugs for disorders of the endocrine system

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/015021 Priority application(s): WO2008/015021

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007280673-Apparatus for producing and/or processing panels

2007280636-Delayed-release glucocorticoid treatment of rheumatoid disease